
A new at-home spit test for prostate cancer could allow thousands of men to have the disease diagnosed at an earlier stage and save the NHS £500 million a year.
The PRODICT test, led by researchers at the Institute for Cancer Research (IRC) in London, analyses saliva to identify the risk of prostate cancer.